- Home
- OMGA vs CCEL Comparison
OMGA vs CCEL Comparison
Compare OMGA & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMGA
- CCEL
- Stock Information
- Founded
- OMGA 2017
- CCEL 1989
- Country
- OMGA United States
- CCEL United States
- Employees
- OMGA N/A
- CCEL N/A
- Industry
- OMGA Biotechnology: Pharmaceutical Preparations
- CCEL Managed Health Care
- Sector
- OMGA Health Care
- CCEL Health Care
- Exchange
- OMGA Nasdaq
- CCEL Nasdaq
- Market Cap
- OMGA 53.6M
- CCEL 50.0M
- IPO Year
- OMGA 2021
- CCEL 1997
- Fundamental
- Price
- OMGA $0.55
- CCEL $7.40
- Analyst Decision
- OMGA Strong Buy
- CCEL
- Analyst Count
- OMGA 5
- CCEL 0
- Target Price
- OMGA $9.20
- CCEL N/A
- AVG Volume (30 Days)
- OMGA 278.9K
- CCEL 13.7K
- Earning Date
- OMGA 11-14-2024
- CCEL 02-26-2025
- Dividend Yield
- OMGA N/A
- CCEL 3.38%
- EPS Growth
- OMGA N/A
- CCEL N/A
- EPS
- OMGA N/A
- CCEL N/A
- Revenue
- OMGA $8,095,000.00
- CCEL $31,838,476.00
- Revenue This Year
- OMGA $181.38
- CCEL $3.97
- Revenue Next Year
- OMGA N/A
- CCEL $0.91
- P/E Ratio
- OMGA N/A
- CCEL N/A
- Revenue Growth
- OMGA 185.04
- CCEL 1.95
- 52 Week Low
- OMGA $0.52
- CCEL $4.47
- 52 Week High
- OMGA $4.46
- CCEL $9.50
- Technical
- Relative Strength Index (RSI)
- OMGA 29.98
- CCEL 46.30
- Support Level
- OMGA $0.52
- CCEL $6.74
- Resistance Level
- OMGA $0.67
- CCEL $7.50
- Average True Range (ATR)
- OMGA 0.09
- CCEL 0.42
- MACD
- OMGA -0.02
- CCEL -0.02
- Stochastic Oscillator
- OMGA 5.95
- CCEL 56.42
About OMGA Omega Therapeutics Inc.
Omega Therapeutics Inc is a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to biologically engineer a new class of programmable epigenetic medicines, known as Omega Epigenomic Controllers. Using epigenomic controllers, Omega is seeking to transform the practice of human medicine through selective and direct control of the human genome to treat and cure disease. It operates in the U.S.
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from cellular processing and cryogenic storage and it derives revenue from processing and testing fees and storage segment.